Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian P Rubin

Showing results (211-220 of 258) with videos related to

Pageof 26
Sort By:
Molecular Imaging and Biology|July 10, 2010
MicroCT-based virtual histology evaluation of preclinical medulloblastomaSuresh I Prajapati, Aoife Kilcoyne, Aislynn K Samano, et al.
International Journal of Cancer|May 9, 2020
Oncogenic properties and signaling basis of the PAX8-GLIS3 fusion geneThais Basili, Higinio Dopeso, Sarah H Kim, et al.
Archives of Pathology & Laboratory Medicine|April 7, 2010
Protocol for the examination of specimens from patients with tumors of soft tissueBrian P Rubin, Kumarasen Cooper, Christopher D M Fletcher, et al.
British Journal of Cancer|February 23, 2019
Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumoursCésar Serrano, Adrián Mariño-Enríquez, Derrick L Tao, et al.
British Journal of Cancer|May 25, 2019
Correction: Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumoursCésar Serrano, Adrián Mariño-Enríquez, Derrick L Tao, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 13, 2006
A landscape effect in tenosynovial giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumor cellsRobert B West, Brian P Rubin, Melinda A Miller, et al.
Histopathology|February 13, 2013
Mutation profiling of adenoid cystic carcinomas from multiple anatomical sites identifies mutations in the RAS pathway, but no KIT mutationsDaniel Wetterskog, Paul M Wilkerson, Daniel N Rodrigues, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 31, 2016
Loss of H3K27 tri-methylation is a diagnostic marker for malignant peripheral nerve sheath tumors and an indicator for an inferior survivalArjen Hg Cleven, Ghadah A Al Sannaa, Inge Briaire-de Bruijn, et al.
Oncogene|August 25, 2004
Gastrointestinal stromal tumors (GISTs) with KIT and PDGFRA mutations have distinct gene expression profilesSubbaya Subramanian, Robert B West, Christopher L Corless, et al.
The Journal of Pathology|November 24, 2015
Uterine adenosarcomas are mesenchymal neoplasmsSalvatore Piscuoglio, Kathleen A Burke, Charlotte K Y Ng, et al.
Pageof 26

Showing results (211-220 of 258) with videos related to

Sort By:
Pageof 26
Molecular Imaging and Biology|July 10, 2010
MicroCT-based virtual histology evaluation of preclinical medulloblastomaSuresh I Prajapati, Aoife Kilcoyne, Aislynn K Samano, et al.
International Journal of Cancer|May 9, 2020
Oncogenic properties and signaling basis of the PAX8-GLIS3 fusion geneThais Basili, Higinio Dopeso, Sarah H Kim, et al.
Archives of Pathology & Laboratory Medicine|April 7, 2010
Protocol for the examination of specimens from patients with tumors of soft tissueBrian P Rubin, Kumarasen Cooper, Christopher D M Fletcher, et al.
British Journal of Cancer|February 23, 2019
Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumoursCésar Serrano, Adrián Mariño-Enríquez, Derrick L Tao, et al.
British Journal of Cancer|May 25, 2019
Correction: Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumoursCésar Serrano, Adrián Mariño-Enríquez, Derrick L Tao, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 13, 2006
A landscape effect in tenosynovial giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumor cellsRobert B West, Brian P Rubin, Melinda A Miller, et al.
Histopathology|February 13, 2013
Mutation profiling of adenoid cystic carcinomas from multiple anatomical sites identifies mutations in the RAS pathway, but no KIT mutationsDaniel Wetterskog, Paul M Wilkerson, Daniel N Rodrigues, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 31, 2016
Loss of H3K27 tri-methylation is a diagnostic marker for malignant peripheral nerve sheath tumors and an indicator for an inferior survivalArjen Hg Cleven, Ghadah A Al Sannaa, Inge Briaire-de Bruijn, et al.
Oncogene|August 25, 2004
Gastrointestinal stromal tumors (GISTs) with KIT and PDGFRA mutations have distinct gene expression profilesSubbaya Subramanian, Robert B West, Christopher L Corless, et al.
The Journal of Pathology|November 24, 2015
Uterine adenosarcomas are mesenchymal neoplasmsSalvatore Piscuoglio, Kathleen A Burke, Charlotte K Y Ng, et al.
Pageof 26